Sildenafil NDC 33342-041

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-041Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0041Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-041-07	33342004107	30 TABLET, FILM COATED in 1 BOTTLE (33342-041-07)Marketed from Apr 19, 2023
33342-041-11	33342004111	100 TABLET, FILM COATED in 1 BOTTLE (33342-041-11)Marketed from Apr 19, 2023
33342-041-44	33342004144	1000 TABLET, FILM COATED in 1 BOTTLE (33342-041-44)Marketed from Apr 19, 2023
33342-041-98	33342004198	1 BLISTER PACK in 1 CARTON (33342-041-98) / 60 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Apr 19, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sildenafil
Generic name (nonproprietary): sildenafil
Active ingredients: Sildenafil citrate — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202255
Marketing start: Apr 19, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers: Product ID 33342-041_e89d523d-8d42-4bbf-be3d-2b15e7c15f4fSPL ID e89d523d-8d42-4bbf-be3d-2b15e7c15f4fSPL set ID c2b25818-99a3-474b-a04c-929df1110834RxCUI 312950, 314228, 314229UNII BW9B0ZE037UPC 0333342043443, 0333342042446
Pharmacologic class: Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342004107 followed by a unit qualifier and the quantity

Package 33342-0041-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 17, 2025.

Indications (excerpt from the label)

Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil tablets are phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202255

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202255
Product	Strength	Form · route	Labeler	Product NDC
Sildenafil	Sildenafil citrate 50 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-042
Sildenafil	Sildenafil citrate 100 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-043
Sildenafil	Sildenafil citrate 50 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7977
Sildenafil	Sildenafil citrate 50 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals, Inc.	68071-3978